Human Influenza Virus Real-time RT-PCR Detection and Characterization Panel

Description: This invention relates to methods of rapidly detecting influenza, including differentiating between type and subtype. Unlike culture and serological tests requiring 5 to 14 days for completion, CDC researchers developed a rapid, accurate assay, which is easily adapted to kit form. This assay also requires less labor input than immunoassays. These methods can be used to quickly identify a broad variety of influenza types and subtypes, including viruses that may be involved in pandemics (such as H5N1, for example).

Category(s):

Licensing

Infectious Disease

Therapeutics

Consumer Products

Occupational Safety and Health

Diagnostics

Research Materials